Search
8 results for “Hapvida”
Brazil’s Health Regulator Briefly Suspends Hapvida Premium Hikes, Exposing Sector Volatility
Brazil’s ANS briefly halted Hapvida’s planned premium hikes affecting nearly 1 million policyholders, only to reverse the decision a day later.
Hapvida Targets Higher Margin with NotreDame Saúde Premium Launch
Hapvida (HAPV3) is launching a premium health plan in August under the NotreDame Saúde brand, aiming for margin expansion.
Hapvida (HAPV3) Pivots to Premium Segment with August Launch of 'NotreDame Saúde'
Brazil's Hapvida (HAPV3) is launching a premium health plan brand, 'NotreDame Saúde,' to target higher-margin clients and boost Average Ticket Per User.
Hapvida (HAPV3) Launches Premium 'NotreDame Saúde' Line, Pivoting From Verticalized Model
Hapvida's new premium plan targets high-income segment, offering access to top-tier hospitals like Einstein and Sírio-Libanês, breaking its traditional model.
Hapvida Decline Highlights Volatility Across B3 Stocks
Shares of Brazilian healthcare giant Hapvida dropped 5.25% on Monday, diverging from the broader Ibovespa as medical claims anxiety persists.
Hapvida (HAPV3) Pivots to Premium Segment with NotreDame Saúde to Boost Average Ticket
Hapvida launches 'NotreDame Saúde' brand in August, focusing on high-margin premium plans to lift profitability, marking a shift in strategy.
Hapvida Premium Push Threatens Small-Cap Health Competitors
Hapvida launches its NotreDame Saúde premium brand, shifting from its vertical model and heightening competitive pressure on niche Brazilian healthcare peers.
Hapvida Premium Plan Entry Threatens Small-Cap Hospital Stocks
Hapvida's launch of the NotreDame Saúde premium plan enters high-margin territory, threatening small-cap hospital operators like Mater Dei and Kora Saúde.